Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInventory AverageInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Unicycive Therapeutics (UNCY) EBT Margin (2022 - 2023)

Unicycive Therapeutics filings provide 2 years of EBT Margin readings, the most recent being 622.22% for Q1 2023.

  • On a quarterly basis, EBT Margin changed N/A to 622.22% in Q1 2023 year-over-year; TTM through Dec 2023 was 2998.67%, a N/A change, with the full-year FY2023 number at 2998.67%, down 109982.0% from a year prior.
  • EBT Margin hit 622.22% in Q1 2023 for Unicycive Therapeutics, down from 584.33% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 584.33% in Q3 2022 to a low of 622.22% in Q1 2023.